Gerson Lehrman Group - Intelligently Connecting Institutions and Expertise.

Expert Insights on Cardiology

Cardiology is the field of medicine focused on the treatment of disorders and diseases of the cardiovascular system, namely the heart and blood vessels. Cardiology is divided into specialties that focus on intervention, heart failure, hypertension, lipid management, nuclear cardiology, and electrophysiology.

Gerson Lehrman Group Council Members are available to discuss Cardiology via phone consultations, live meetings, surveys, and other custom GLG products and services.

Find, engage, and manageSM experts today through the GLG platform

Featured Council Members

GLG Council Members are leading experts including academics, scientists, and industry specialists

Giuseppe Biondi-Zoccai, MD, Assistant Professor of Cardiology , University of Turin

Giuseppe Biondi-Zoccai, MDWhat is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Assistant Professor of Cardiology University of Turin

Michael Davidson, MD, FACC, Director, Preventive Cardiology, THE UNIVERSITY OF CHICAGO

Michael Davidson, MD, FACCWhat is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Director, Preventive CardiologyTHE UNIVERSITY OF CHICAGO

Barry Massie, MD, Chief of the Cardiology Division , San Francisco Veterans Affairs Medical Center

Barry Massie, MDWhat is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Chief of the Cardiology Division San Francisco Veterans Affairs Medical Center

Charles O'Shaughnessy, MD, Director of Interventional Cardiology, NORTH OHIO HEART CENTER, INC

Charles O'Shaughnessy, MDWhat is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Director of Interventional CardiologyNORTH OHIO HEART CENTER, INC

Goran Olivecrona, MD, PhD., Consulting Cardiologist, University of Lund

Goran Olivecrona, MD, PhD.What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Consulting CardiologistUniversity of Lund

Browse all 407 Leading Experts

Study Groups

Study groups are populations of experts knowledgeable on specific sub-topics within a broader industry

Study Group Name No. Members
Cardiology Device Distributors 69
Cardiologists who Implant ICDs (EU) 84
Electrophysiologists who Treat Patients with Arrhythmias and Implant ICDs (EU) 20
Perfusionists 12
Physicians who Implant the COSTAR Drug Eluting Stent 31

Browse all 974 Study Groups

Recent Live Meetings

Interactive roundtables, private visits, and small scale seminars are types of GLG Live Meetings

September 29, 2009 | New York

Seminar: Interventional Cardiology - Post-TCT 2009 Data Driven Analysis of Stent Market (New York)

Recent News Analyses

News analyses are expert commentaries on current events, written by Council Members who are available for follow up consultations

Percutaneous valve repair – next battle among cardiovascular device companies?

October 4, 2009

GLG Expert Contributor

Abbott To Acquire Evalve, Inc., A Leader In Minimally Invasive Cardiac Valve Repair Technology | www.medicalnewstoday.com

By acquiring promising technology in the percutaneous valve arena, as well as enjoying an already established reputation among interventional cardiologists, Abbott will position itself as a major player in an emerging technology market, and become a comprehensive provider for interventional cardiology...

The Logical Next Step for Abbott

September 15, 2009

GLG Expert Contributor

Abbott To Acquire Evalve, Inc., A Leader In Minimally Invasive Cardiac Valve Repair Technology | www.medicalnewstoday.com

With this acquisition Abbott establishes its position as a major player in the field of interventional cardiology and treatment of structural heart disease.The field of structural heart disease therapy is the fastest growing area of interventional cardiology and Abbott is getting in at the ground floor.In...

Browse all 7647 GLG News Analyses

Contact Gerson Lehrman Group to engage a Cardiology expert